FDC has informed that the Company has been granted ANDA approval by United States Food and Drug Administration (U.S.FDA), for Cefixime for Oral Suspension USP, 100 mg / 5 mL and 200 mg/ 5 ml.
The above information is a part of company’s filings submitted to BSE.